Santosh Kesari

University of California, San Diego
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 72 Citations 22,820 495 World Ranking 16199 National Ranking 8243

Overview

What are the main themes of her work throughout her whole career to date

Santosh Kesari combines Nuclear medicine and Standardized uptake value in her research. Santosh Kesari incorporates Standardized uptake value and Fluorodeoxyglucose in her studies. She undertakes interdisciplinary study in the fields of Fluorodeoxyglucose and Positron emission tomography through her research. Santosh Kesari combines Positron emission tomography and Nuclear medicine in her research. Many of her studies on Glioma apply to Cancer research as well. Her study on Cancer research is mostly dedicated to connecting different topics, such as Glioma. Santosh Kesari integrates many fields in her works, including Lesion and Magnetic resonance imaging. Her multidisciplinary approach integrates Magnetic resonance imaging and Lesion in her work. Her research links Internal medicine with Receiver operating characteristic.

Santosh Kesari most often published in these fields:

Nuclear medicine (100.00%)
Standardized uptake value (100.00%)
Fluorodeoxyglucose (100.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Malignant Gliomas in Adults

Patrick Y Wen;Santosh Kesari.
The New England Journal of Medicine (2008)

4463 Citations

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

Galina Gabriely;Thomas Wurdinger;Santosh Kesari;Christine C. Esau.
Molecular and Cellular Biology (2008)

1069 Citations

Maintenance therapy with tumor-Treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trial

Roger Stupp;Roger Stupp;Sophie Taillibert;Andrew A. Kanner;Santosh Kesari.
JAMA (2015)

999 Citations

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky.
Neurology (2008)

936 Citations

Transdifferentiation of glioblastoma cells into vascular endothelial cells

Yasushi Soda;Tomotoshi Marumoto;Tomotoshi Marumoto;Dinorah Friedmann-Morvinski;Mie Soda.
Proceedings of the National Academy of Sciences of the United States of America (2011)

533 Citations

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Keith L. Ligon;Emmanuelle Huillard;Emmanuelle Huillard;Shwetal Mehta;Santosh Kesari.
Neuron (2007)

532 Citations

Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors

Hiroaki Wakimoto;Santosh Kesari;Christopher J. Farrell;William T. Curry.
Cancer Research (2009)

362 Citations

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Linda M. Liau;Keyoumars Ashkan;David D. Tran;Jian L. Campian.
Journal of Translational Medicine (2018)

324 Citations

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy

Paul G. Richardson;Wanling Xie;Constantine Mitsiades;Asher A. Chanan-Khan.
Journal of Clinical Oncology (2009)

323 Citations

Human Glioma Growth is Controlled by MicroRNA-10b

Galina Gabriely;Ming Yi;Ravi S. Narayan;Johanna M. Niers.
Cancer Research (2011)

312 Citations

If you think any of the details on this page are incorrect, let us know.